story of the week
Ivosidenib and Azacitidine for IDH1-Mutated AML
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia
N. Engl. J. Med 2022 Apr 21;386(16)1519-1531, P Montesinos, C Recher, S Vives, E Zarzycka, J Wang, G Bertani, M Heuser, RT Calado, AC Schuh, SP Yeh, SR Daigle, J Hui, SS Pandya, DA Gianolio, S de Botton, H DöhnerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.